These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 11438820)
1. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome. Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820 [TBL] [Abstract][Full Text] [Related]
2. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738 [TBL] [Abstract][Full Text] [Related]
3. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
4. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Lickliter JD; McGlave PB; DeFor TE; Miller JS; Ramsay NK; Verfaillie CM; Burns LJ; Wagner JE; Eastlund T; Dusenbery K; Weisdorf DJ Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652 [TBL] [Abstract][Full Text] [Related]
5. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation. Cornelissen JJ; Fibbe WE; Schattenberg AV; Petersen EJ; Willemze R; de Witte TJ; Löwenberg B; Verdonck LF; vd Biezen A; Brand R Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S66-70. PubMed ID: 9712499 [TBL] [Abstract][Full Text] [Related]
6. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow. Nivison-Smith I; Bradstock KF; Szer J; Durrant S; Dodds A; Hermann R; Schwarer AP; Gibson J; To LB; Arthur C; Bone Marrow Transplant; 2001 Jul; 28(1):21-7. PubMed ID: 11498740 [TBL] [Abstract][Full Text] [Related]
8. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784 [TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931 [TBL] [Abstract][Full Text] [Related]
11. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study. Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741 [TBL] [Abstract][Full Text] [Related]
12. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551 [TBL] [Abstract][Full Text] [Related]
13. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia]. Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Kato S; Yabe H; Yasui M; Kawa K; Yoshida T; Watanabe A; Osugi Y; Horibe K; Kodera Y Bone Marrow Transplant; 2000 Dec; 26(12):1281-90. PubMed ID: 11223967 [TBL] [Abstract][Full Text] [Related]
15. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
16. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D; Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR; Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study. Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience. Bacigalupo A; Zikos P; Van Lint MT; Valbonesi M; Lamparelli T; Gualandi F; Occhini D; Mordini N; Bregante S; Berisso G; Vitale V; Sessarego M; Marmont AM Exp Hematol; 1998 May; 26(5):409-14. PubMed ID: 9590657 [TBL] [Abstract][Full Text] [Related]
20. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]